Device Stakeholders Debate Whether FDA Can, Or Should, Revoke 510(k)s

FDA should have no reason to rescind 510(k) substantial equivalence decisions for marketed devices except in extreme cases of fraud, device industry lobbyists said in recent comments to FDA

More from Archive

More from Medtech Insight